Hongyang Wang
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
Papers in
-
- RNA modifications and cancer 28
-
- MicroRNA in disease regulation 32
- Cancer-related molecular mechanisms research 17
- Co-authors
- Lei Chen (47 shared papers)Yexiong Tan (57 shared papers)Mengchao Wu (46 shared papers)Le‐Xing Yu (20 shared papers)Jin Ding (29 shared papers)Bo Zheng (13 shared papers)Jing Fu (18 shared papers)Yanjing Zhu (14 shared papers)
- Journals
- Hepatology (28 papers)Cancer Letters (26 papers)Journal of Hepatology (9 papers)Cancer Research (9 papers)Acta Pharmacologica Sinica (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Hongyang Wang
458 papers receiving 22.3k citations
Hongyang Wang's Hit Papers
Peers
Comparison fields: 5 of 178
- Cancer Research 5.6k
- Hepatology 2.6k
- Immunology 3.3k
- Molecular Biology 10.9k
- Oncology 4.0k
Countries citing papers authored by Hongyang Wang
This map shows the geographic impact of Hongyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Wang more than expected).
Fields of papers citing papers by Hongyang Wang
This network shows the impact of papers produced by Hongyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Wang. The network helps show where Hongyang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongyang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 474 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Hit paper breakdown → | 2018 | 790 |
| 2 | A family of proteins that inhibit signalling through tyrosine kinase receptors Hit paper breakdown → | 1997 | 575 |
| 3 | New knowledge of the mechanisms of sorafenib resistance in liver cancer Hit paper breakdown → | 2017 | 541 |
| 4 | Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing Hit paper breakdown → | 2020 | 533 |
| 5 | 2009 | 438 | |
| 6 | 2013 | 348 | |
| 7 | 2008 | 307 | |
| 8 | 2017 | 300 | |
| 9 | 2010 | 278 | |
| 10 | 2011 | 275 | |
| 11 | 2020 | 273 | |
| 12 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Hit paper breakdown → | 2020 | 272 |
| 13 | 2014 | 262 | |
| 14 | 2010 | 261 | |
| 15 | 2016 | 258 | |
| 16 | 2017 | 245 | |
| 17 | 2018 | 239 | |
| 18 | 2015 | 233 | |
| 19 | 2017 | 229 | |
| 20 | 2013 | 226 |
About Hongyang Wang
Hongyang Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 474 papers that have together received 22.5k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), MicroRNA in disease regulation (32 papers), RNA modifications and cancer (28 papers), Liver physiology and pathology (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (18 papers) and Cancer-related molecular mechanisms research (17 papers). The work is most often cited by research in Cancer Research (5.6k citations), Hepatology (2.6k citations), Immunology (3.3k citations), Molecular Biology (10.9k citations) and Oncology (4.0k citations). Hongyang Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Lei Chen, Yexiong Tan, Mengchao Wu, Le‐Xing Yu, Jin Ding, Bo Zheng, Jing Fu, Yanjing Zhu, Wen Yang and Liwei Dong. Their work appears in journals such as Hepatology, Cancer Letters, Journal of Hepatology, Cancer Research and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.